Dr. Jonathan C. Trent is a board-certified oncologist who has dedicated his career to researching and treating cancer. An Oklahoma native, Dr. Trent attended Southeastern Oklahoma State University and the University of Texas. He earned his board certification from the American Board of Internal Medicine in 1999.

Oncology was a personal decision for Dr. Trent after his grandmother died of cancer. His expertise in oncology and his passion for lab research led to him becoming a widely recognized sarcoma specialist.

In 2002, Dr. Trent became an assistant professor at the department of sarcoma medical oncology at the University of Texas’ M.D. Anderson Cancer Center in Houston, Texas. He has produced more than 100 peer-reviewed articles, served on many editorial boards and presented at numerous conferences.

In 2011, Dr. Trent was appointed professor of medicine and co-director of the musculoskeletal center in the department of medicine at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. His team focuses on developing breakthroughs in gene discovery that enable improved precision medicine for cancer patients.

Throughout his career, Dr. Trent has incorporated research and teaching into treating patients. His research has been used to devise treatments for patients based upon their individual needs. These treatments include medicines Dr. Trent developed that target the specific genes a cancer uses to grow in a patient. Patients are now receiving care designed to attack the specific cancer in their own bodies.

Dr. Trent serves on the Sylvester Comprehensive Cancer Center’s executive committee as the associate director for clinical research.